Cargando…
Steroids Therapy in Patients With Severe COVID-19: Association With Decreasing of Pneumonia Fibrotic Tissue Volume
BACKGROUND: We use longitudinal chest CT images to explore the effect of steroids therapy in COVID-19 pneumonia which caused pulmonary lesion progression. MATERIALS AND METHODS: We retrospectively enrolled 78 patients with severe to critical COVID-19 pneumonia, among which 25 patients (32.1%) who re...
Autores principales: | He, Jin-wei, Su, Ying, Qiu, Ze-song, Wu, Jiang-jie, Chen, Jun, Luo, Zhe, Zhang, Yuyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329540/ https://www.ncbi.nlm.nih.gov/pubmed/35911397 http://dx.doi.org/10.3389/fmed.2022.907727 |
Ejemplares similares
-
Usage of compromised lung volume in monitoring steroid therapy on severe COVID-19
por: Su, Ying, et al.
Publicado: (2022) -
Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity
por: Wu, Cichun, et al.
Publicado: (2021) -
Surviving Pneumonia: A Rare Outcome of Compensatory Hyperinflation in Fibrotic Lung Disease
por: Kumar, Mukesh, et al.
Publicado: (2023) -
Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021) -
Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis
por: Oh, Ju Hyun, et al.
Publicado: (2023)